Malaria Diagnostics Market - Forecast(2025 - 2031)

Malaria Diagnostics Market Overview

Malaria Diagnostics Market Size is forecast to reach $ 1,201.2 Million by 2030, at a CAGR of 4.5% during forecast period 2024-2030. According to the 2024 World Malaria Report, around half of the world's population live in areas at risk of malaria transmission in 87 countries and territories. In 2023, malaria caused an estimated 241 million clinical episodes and 627,000 deaths. The growing demand for diagnostic tools in malaria-endemic regions along with increasing technological advancements provides a moderate outlook for the malaria diagnostics industry for the projected period of 2024-2030. The infected mosquito transmits the plasmodium parasite which leads to the development of malaria. Various cross-sectional research claims that a timely diagnosis of malaria can help reduce the disease's mortality. Hence, diagnostics aided by microscopy, rapid diagnostics tests or molecular diagnostic tests aid the authorities to mitigate the high disease treatment cost. Malaria diagnostics are actively performed in various hospitals and clinics and highly performed in diagnostic centers due to rampant workflow and advanced technology presence. 

Malaria Diagnostics Market Report Coverage

The report: “Malaria Diagnostics Market Forecast (2024-2030)" by IndustryARC, covers an in-depth analysis of the following segments in the Malaria Diagnostics Market.

By Technology: Rapid Diagnostic Test, Molecular Diagnostic Test, Microscopy, Serology, Spectroscopy, Nucleic Acid Detection and Hemozoin Detection.

By End-user: Hospitals, Clinics, Diagnostic Centers and Others.

By Geography: North America (the U.S., Canada and Mexico), Europe (Germany, the UK, France, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan India, South Korea, Australia and New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and the Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Takeaways

• Geographically, the Rest of the World (the Middle East and Africa) held a dominant market share in 2023 and is expected to offer lucrative opportunities in the forecast period of 2024-2030. It is due to a predominant form of disease spread in the region, assisted by a plethora of diagnostic support from leading organizations.
• Significant spread of the particular infection in the region complimented by high fatality rates in late detection and rising support from leading government and non-government agencies proliferate the market growth. However, better termination of malaria-spreading mosquitos due to superior civil infrastructure in semi-developed and highly-developed nations impedes the market growth.
• A detailed analysis of the strengths, weaknesses, opportunities and threats would be provided in the Malaria Diagnostic Market Report.

Malaria Diagnostics Market Segment Analysis - by Technology

The Malaria Diagnostics Market based on technology can be further segmented into Rapid Diagnostic Tests, Molecular Diagnostic Tests, Microscopy, Serology, Spectroscopy, Nucleic Acid Detection and Hemozoin Detection. Microscopy held a dominant market size in 2023. The CDC identifies microscopy tests to be the “gold standard” for laboratory confirmation against malaria. These tests have high specificity and are often recommended by top healthcare authorities. Lastly, microscopy-based tests are relatively simple and can be accessed and used by most laboratories across the world. However, Rapid Diagnostic Tests are estimated to be the fastest-growing one, with a CAGR of 4.5% over the forecast period of 2024-2030. It is due to the higher coverage ratio these tests provide. The rapid RDTs detect specific antigens produced by malaria parasites in the blood. Critical innovation aids the overall market, as nearly 280 million suspected malaria cases were nearly tested in 2022 alone. The advent of better technology can increase the said testing capacity further.

Malaria Diagnostics Market Segment Analysis - by End-user

The Malaria Diagnostics Market based on end-users can be further segmented into Hospitals, Clinics, Diagnostic Centers and Others. The Diagnostic Centers segment held a dominant market share in 2023 and is estimated to be the fastest-growing segment, with a CAGR of 4.5% over the forecast period of 2024-2030. It is due to the better technological grip and specific manpower to perform various forms of microbiological and diagnostic tests. Additionally, the labs present in the LAMEA countries are aided by various organizations - both private and public companies. For example, Path Labs and CDC now aid nearly 120 public labs in Africa. Additionally, various phlebotomists are receiving training on advanced levels to accelerate disease detection to curb the overall mortality of malaria.

Malaria Diagnostics Market Segment Analysis - by Geography

The Malaria Diagnostics Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and the Rest of the World. The Rest of the World held a dominant market share of nearly 43% in 2023 and is expected to offer lucrative growth opportunities over the forecast period of 2023-2028. It is simply due to the vast prevalence of the disease in the region. As per the WHO 2022 Malaria Report, in 2020, nearly 228,000 new cases of malaria were detected in the WHO Africa region which approximately led to 95% of all cases worldwide, with nearly 96% of all deaths in the region. Furthermore, major forms of disease assistance in terms of diagnostic tests are provided by leading organizations and country-specific associations.

Malaria Diagnostics Market Drivers

A Widespread Disease Burden:

This particular disease is spread through the bite of an infected female Anopheles mosquito. The spread of this disease is influenced by the season, with the highest risk in rainy seasons within tropical regions. As per WHO, nearly half of the world’s population is at risk of malaria with nearly 241 million estimated cases in 2020 alone (85 Countries). Thus, the disease burden is even higher. Critically, the disease spread is proliferated in certain age groups, such as infants and children under the age of 5, pregnant women and patients with HIV/AIDS. All these criteria are present in the LAMEA regions which aid in the growth of cases.

Growing Support from Government and Non-government Bodies:

The support from authorities has had a major influence on the diagnosis and treatment of malaria. Various cross-sectional studies have identified that a delayed test or diagnosis correlated with higher mortality from this disease. Hence, authorities all around the world pay major heed to the deployment of rapid diagnostic tests to pave an efficient treatment regimen. Further, the Global Fund 2020 provided for nearly 63% of all international financing for malaria programs, with an investment of more than $16.4 billion in malaria control programs as of June 2022. WHO recommends microscopy and rapid diagnostic tests for all patients with suspected malaria before any given treatment.

Malaria Diagnostics Market Challenge

Better Termination of Malaria-spreading Mosquitos due to Superior Civil Infrastructure in Semi-developed and Highly-developed Nations:

As per NCBI and World Malaria Report, malaria case incidence has reduced by 41% and mortality rates reduced by nearly 62% in the last two decades. Also, more than 100 countries have eliminated malaria in the past century. Malaria prevention techniques have superseded and have achieved success in various settings. For example, in developed and semi-developed regions, the disease-spreading mosquitos have nearly been eradicated. Additionally, various regions have made civic bodies extremely vigilant to mitigate any contamination source. These reasons mitigate the disease spread, thus impeding the overall use of Malaria Diagnostics.

Malaria Diagnostics Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Malaria Diagnostics Industry. The top 10 companies in the Malaria Diagnostics Market are:

1. Access Bio Inc
2. Abbott Laboratories
3. BioMeriux SA
4. Thermofisher Scientific
5. Siemens Healthineers
6. Premier Medical Corporation
7. Siemens Healthineers
8. Bio-Rad Labs
9. Advy Chemicals Pvt Ltd.
10. Adva Care Pharma

Recent Developments

• In October 2023, Noul - a Korean Medical Diagnostics Company - signed a memorandum of understanding with the Institute Pasteur Cameroon to strengthen malaria diagnosis and implement joint research in the Central African Country.
• In February 2023, KEMRI or Kenya Medical Research Institute launched a Malaria Detection Testing Kit. The kit was named PlASMOCHEK. The product would cost 60 shillings to target against the hospitals' cost of nearly 300 shillings.

For more Lifesciences and Healthcare Market reports, please click here